EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Common Regulators of Lipid Metabolism and Bone Marrow Adiposity in Postmenopausal Women

Dae-Yong Kim, Seong-Hee Ko iD

Pharmaceuticals · 20.02.2023 · 16 (2) · 322

DOI: 10.3390/ph16020322 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Pharmaceuticals, online erschienen am 20.02.2023. Verfasst von Dae-Yong Kim und 1 weiteren Autor:innen. Beteiligte Einrichtung: CEO, N- BIOTEK, Inc., 402-803, Technopark, 655, Pyeongcheon-ro, Bucheon-si 14502, Gyeonggi-do, Republic of Korea. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 93 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

A variety of metabolic disorders are associated with a decrease in estradiol (E2) during natural or surgical menopause. Postmenopausal women are prone to excessive fat accumulation in skeletal muscle and adipose tissue due to the loss of E2 via abnormalities in lipid metabolism and serum lipid levels. In skeletal muscle and adipose tissue, genes related to energy metabolism and fatty acid oxidation, such as those encoding peroxisome proliferator-activated receptor-γ coactivator 1α (PGC-1α) and estrogen-related receptor alpha (ERRα), are downregulated, leading to increased fat synthesis and lipid metabolite accumulation. The same genes regulate lipid metabolism abnormalities in the bone marrow. In this review, abnormalities in lipid metabolism caused by E2 deficiency were investigated, with a focus on genes able to simultaneously regulate not only skeletal muscle and adipose tissue but also bone metabolism (e.g., genes encoding PGC-1α and ERRα). In addition, the mechanisms through which mesenchymal stem cells lead to adipocyte differentiation in the bone marrow as well as metabolic processes related to bone marrow adiposity, bone loss, and osteoporosis were evaluated, focusing on the loss of E2 and lipid metabolic alterations. The work reviewed here suggests that genes underlying lipid metabolism and bone marrow adiposity are candidate therapeutic targets for bone loss and osteoporosis in postmenopausal women.

Schlagwörter

Stichwörter der Autor:innen

bone lossbone marrow adipositydysregulated lipid metabolismestradiol lossestrogen-related receptor alphaosteoporosisperoxisome proliferator-activated receptor-γ coactivator 1α

Autor:innen und Institutionen

  • CEO, N- BIOTEK, Inc., 402-803, Technopark, 655, Pyeongcheon-ro, Bucheon-si 14502, Gyeonggi-do, Republic of Korea.
  • Regenerative Medicine Research Team, N- BIOTEK, Inc., 104-706, Technopark Ssangyong 3Cha, 397, Seokcheon-ro, Bucheon-si 14449, Gyeonggi-do, Republic of Korea.

ORCID-Profile: Seong-Hee Ko

Zitieren

APA

Kim, D. Y., & Ko, S. H. (2023). Common Regulators of Lipid Metabolism and Bone Marrow Adiposity in Postmenopausal Women. Pharmaceuticals, 16(2), 322. https://doi.org/10.3390/ph16020322

Vancouver

Kim DY, Ko SH. Common Regulators of Lipid Metabolism and Bone Marrow Adiposity in Postmenopausal Women. Pharmaceuticals. 2023;16(2):322. doi:10.3390/ph16020322

BibTeX
@article{Kim2023,
  author = {Kim, Dae-Yong and Ko, Seong-Hee},
  title = {Common Regulators of Lipid Metabolism and Bone Marrow Adiposity in Postmenopausal Women},
  journal = {Pharmaceuticals},
  year = {2023},
  volume = {16},
  number = {2},
  pages = {322},
  doi = {10.3390/ph16020322}
}
Kostenlos starten →